Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of tOPV Batches in Indonesian Infants
NCT02093273Phase 2Completed
- Sponsor
- Bio Farma
- Start
- May 2013
- Primary completion
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trivalent oral poliovirus vaccine in poliomyelitis, sponsored by Bio Farma. Started May 2013; status: completed.
02
Drugs
trivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT02093273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02093273.